Regorafenib is a multi-kinase inhibitor targeting angiogenic (VEGFR, TIE-2), stromal (PDGFR-β) and oncogenic (RAF, RET and c-KIT) re ceptor tyrosine kinases, with IC₅₀s of 17, 40 and 69 nM for c-KIT, VEGFR2, B-Raf, respectively. Displays potential an

Numéro d'article : BIOV2891-25

Unité de mesure : 25 MG

625.00 CHF 625.0 CHF 625.00 CHF

625.00 CHF

Cette combinaison n'existe pas.

AJOUTER AU PANIER

Délai de livraison actuel sur demande

Fabricant : BIOVISION

Numéro du fabricant : 2891-25

Température de stockage : Freezer (-20)

Regorafenib is a multi-kinase inhibitor targeting angiogenic (VEGFR, TIE-2), stromal (PDGFR-β) and oncogenic (RAF, RET and c-KIT) re ceptor tyrosine kinases, with IC₅₀s of 17, 40 and 69 nM for c-KIT, VEGFR2, B-Raf, respectively. Displays potential an

Regorafenib is a multi-kinase inhibitor targeting angiogenic (VEGFR, TIE-2), stromal (PDGFR-β) and oncogenic (RAF, RET and c-KIT) re ceptor tyrosine kinases, with IC₅₀s of 17, 40 and 69 nM for c-KIT, VEGFR2, B-Raf, respectively. Displays potential an

625.00 CHF 625.0 CHF 625.00 CHF

625.00 CHF

Not Available For Sale